Trust and guidance for clinicians |
Automatically approval of treatment could be perceived as a sign that that the claims managers trust the clinicians’ judgement |
Limiting over-servicing |
Recommendations about MRIs and certain surgeries could limit over-servicing, although solicitors could still get it anyway |
Patient expectations and claimant monitoring |
Tool may assist with managing patient expectations, as it sets timeframes about RTW |
Individual differences & psychosocial factors |
Tool may inadequately consider individual differences and psychosocial factors. Most patients are not one size fits all |
Clinical judgement |
Clinical judgement is important. Tool should not overpass clinical judgement |
Patient preference |
Some patients prefer to have non evidence based treatments but in general those patients can be convinced to value EBM |
Quality of evidence |
For many topics the evidence is not replicated, or very specific to certain populations |
Quantity of evidence |
Lack of evidence should not imply denial of treatment |
Timeliness and risk assessment |
Tool may not adequately assess risk of prolonged recovery, and therefore not sufficiently focus on timely treatment |
Critical appraisal and guideline development |
Interpretation of evidence is dependent on who does the interpretation. American tool might not be applicable in Australia |
Claims managers using the EBM tool |
Inexperience or limited training for claims managers could lead to rigid usage and unfair denials |
Tool is no solution |
Tool may not assist with the 20% most problematic cases, and does not recognise employer factors that prolong return to work |